Core Insights - Foreign investment in China is undergoing a significant structural transformation as multinational companies (MNCs) shift capital towards new-economy industries [1][2] - MNCs are increasing investments in high-end manufacturing, healthcare, and pharmaceuticals, while also remaining optimistic about consumption-related sectors like fast-moving consumer goods [2][3] - China is being positioned as a global market for innovation, consumption, and growth by global companies [3] Investment Trends - According to HSBC's Global Trade Pulse Survey, 44% of MNCs view China as the top target market for enhancing global trade capabilities, with around 40% planning to increase manufacturing in China over the next two years [5] - China's vast market size, comprehensive industrial facilities, dynamic innovation ecosystem, and abundant talent continue to attract international investment [6] Financial Instruments - The accumulated issuance of panda bonds, which are yuan-denominated securities from overseas institutions operating in China, has surpassed 1 trillion yuan (approximately US$140 billion) since 2005 [7] - The availability of domestic fundraising tools in China reduces financing costs and enhances the expansion of MNCs, optimizing their asset-liability structures and improving capital allocation efficiency [8]